Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/280340
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Hybrid thermoresponsive nanoparticles containing drug nanocrystals for NIR-triggered remote release

AutorAlejo, Teresa CSIC ORCID; Sebastián, Víctor CSIC ORCID; Mendoza, Gracia; Arruebo, Manuel CSIC ORCID
Palabras claveNIR-activated nanoparticles
Reversible thermoresponsive nanogels
On–off switching release
Bupivacaine nanocrystals
Drug delivery
Fecha de publicación2022
EditorElsevier
CitaciónJournal of Colloid and Interface Science 607(2): 1466-1477 (2022)
ResumenThe on-demand administration of anaesthetic drugs can be a promising alternative for chronic pain management. To further improve the efficacy of drug delivery vectors, high drug loadings combined with a spatiotemporal control on the release can not only relief the pain according to patient’s needs, but also improve the drawbacks of conventional burst release delivery systems. In this study, a hybrid nanomaterial was developed by loading bupivacaine nanocrystals (BNCs) into oligo(ethylene glycol) methyl ether methacrylate (OEGMA)-based thermoresponsive nanogels and coupling them to NIR-absorbing biodegradable copper sulphide nanoparticles (CuS NPs). Those CuS NPs were surface modified with polyelectrolytes using layer-by-layer techniques to be efficiently attached to the surface of nanogels by means of supramolecular interactions. The encapsulation of bupivacaine in the form of nanocrystals allowed to achieve CuS@BNC-nanogels having drug loadings as high as 65.5 wt%. The nanocrystals acted as long-lasting drug reservoirs, leading to an elevated localized drug content, which was useful for their application in prolonged pain relief. The CuS@BNC-nanogels exhibited favorable photothermal transducing properties upon NIR-light irradiation. The photothermal effect granted by the CuS NPs triggered the nano-crystallized drug release to be boosted by the collapse of the thermoresponsive nanogels upon heating. Remote control was achieved for on-demand release at a specific time and place, indicating their potential use as an externally activated triggerable drug-delivery system. Furthermore, cell viability tests and flow cytometry analysis were performed showing satisfactory cytocompatibility in the dose-ranging study having a subcytotoxic concentration of 0.05 mg/mL for CuS@BNC-nanogels. This remotely activated nanoplatform is a promising strategy for long-lasting controlled analgesia and a potential alternative for clinical pain management.
Versión del editorhttps://doi.org/10.1016/j.jcis.2021.09.064
URIhttp://hdl.handle.net/10261/280340
DOI10.1016/j.jcis.2021.09.064
ISSN1095-7103
Aparece en las colecciones: (INMA) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
hybrirele.pdf3,18 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

3
checked on 23-abr-2024

WEB OF SCIENCETM
Citations

2
checked on 28-feb-2024

Page view(s)

27
checked on 30-abr-2024

Download(s)

9
checked on 30-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Este item está licenciado bajo una Licencia Creative Commons Creative Commons